Marinus Verwijs - Nov 2, 2022 Form 4 Insider Report for Aerovate Therapeutics, Inc. (AVTE)

Role
SENIOR VICE PRESIDENT, CMC
Signature
/s/ George A. Eldridge, Attorney-in-Fact
Stock symbol
AVTE
Transactions as of
Nov 2, 2022
Transactions value $
-$21,346
Form type
4
Date filed
11/3/2022, 05:00 PM
Previous filing
Mar 23, 2022
Next filing
Feb 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTE Common Stock Sale -$21.3K -1.13K -100% $18.89 0 Nov 2, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to E*TRADE Securities LLC's Quicksale Trading Plan elected by the reporting person on July 11, 2022.
F2 Includes 1,130 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on October 31, 2022 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d).